Mega-Mergers In The Pharmaceutical Industry

It was called a merger when two companies merged to decide to become a bigger, richer and bigger company. This process formed a new company that combined money and ideas of two different entities in the past. However, as this is not the only factor in merging two different companies, we will not discuss the implications because we will discuss the merger of the two companies in the pharmaceutical industry. Of course, the merger of both companies not only has a positive influence, it also has many negative effects.

This merger is not new in the pharmaceutical industry, but over the past few years the level of drug integration activity is high, and many companies use joint ventures and strategic partnerships to develop and sell new products. The pharmaceutical industry is tightly regulated, highly complex, and full of economic and economic challenges and concerns. Industry financial managers are responsible for a wide range of businesses, including managed care, insurance, refunds, patent and generic competition, licensing, royalties, co-promotion, joint ventures, cooperative marketing rights, high risk and high cost research and development, parallel I am faced with problems. Import issues and international regulations We need to investigate these issues and understand the reasons for the current structure of the industry and how the structure promotes M & A through M & A.

In recent years, as in the history of the merger of Glaxo Wellcome and SmithKline Beecham, the merger is not new in the pharmaceutical industry. Given the political, social and economic resistance, the general driving force of these mergers in this industry is that more companies will develop and sell new products using strategic partnerships and joint ventures It shows that you are interested in it. The pharmaceutical industry dominates the world market, but the US market accounts for 45% of the world market, which will affect the growth of the industry. Therefore it is not surprising that the political, social and economic resistance of the United States has a major impact on the growth of the pharmaceutical industry as a whole.